Results With HUMIRA

Fast relief and lasting remission are possible

Results may be seen in as little as 4 weeks

In clinical studies, a majority of Crohn’s patients on HUMIRA saw symptom relief and many achieved remission (few or no symptoms) at 4 weeks.

In two clinical studies, 58% (Study 1) and 52% (Study 2) of patients taking HUMIRA saw symptom relief at 4 weeks
In two clinical studies, 36% (Study 1) and 21% (Study 2) of patients taking HUMIRA achieved remission at 4 weeks

HUMIRA has helped many people notice a significant difference in their symptoms in as little as 4 weeks; however, individual results may vary. Only you and your doctor can decide if HUMIRA is right for you. Patients who do not see results within 12 weeks should talk to their doctor.

Many patients achieved lasting results with HUMIRA through 56 weeks

HUMIRA was studied in clinical trials. Two studies evaluated how many patients achieved remission within 4 weeks. Then, a third study evaluated how many patients continued to respond to treatment. Ultimately, the study showed that 40% of patients taking HUMIRA achieved and maintained remission at 26 weeks,* and 36% of those patients achieved and maintained remission at 56 weeks.

Individual results may vary.

*Compared to 17% taking placebo.
Compared to 12% taking placebo.

At week 26, 40% of patients taking HUMIRA achieved and maintained remission. At week 56, 36% of patients taking HUMIRA achieved and maintained remission

Remission has allowed me to focus on living in the moment.

- Melissa, a real Crohn’s patient using HUMIRA

Wondering what it’s like to be in remission? Hear from HUMIRA patients who know.

A HUMIRA Testimonial from Dr. Remo Panaccione: “With HUMIRA, remission isn’t just possible, but in many patients, it can be maintained.”
Common side effects of HUMIRA

Common side effects of HUMIRA include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you have any side effect that bothers you or that does not go away.

HUMIRA Complete logo
HUMIRA Complete provides access to a variety of resources
Illustration of a dollar sign
You Could Pay Less Than $5/Month*

Most patients using HUMIRA pay $5 or less per month with copay assistance. If you are a commercially insured patient, you may be able to reduce your out-of-pocket cost with the HUMIRA Complete Savings Card.

Illustration of a question mark
Ongoing Insurance Support

To help you get off to a good start with your HUMIRA prescription, Insurance Specialists will help you understand your HUMIRA coverage and answer any questions you may have.

Has COVID-19 made paying for your medicine a challenge?

AbbVie may be able to help. Call 1.800.4HUMIRA

*Terms and Conditions apply. This benefit covers HUMIRA® (adalimumab) alone or, for rheumatology patients, HUMIRA plus one of the following medications: methotrexate, leflunomide (Arava®), or hydroxychloroquine (Plaquenil®). Eligibility: Available to patients with commercial prescription insurance coverage for HUMIRA who meet eligibility criteria. Co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the HUMIRA Complete Savings card and patient must call HUMIRA Complete at 1-800-4HUMIRA to stop participation. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from the HUMIRA Complete Program from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. Patients who are members of insurance plans that claim to reduce or eliminate their patients' out of pocket co-pay, co-insurance, or deductible obligations for certain prescription drugs based upon the availability of, or patient's enrollment in, manufacturer sponsored co-pay assistance for such drugs (often termed "maximizer" programs) will have an annual maximum program benefit of $6,000.00 per calendar year. This assistance offer is not health insurance. To learn about AbbVie’s privacy practices and your privacy choices, visit www.abbvie.com/privacy.html

Arava and Plaquenil are registered trademarks of their respective owners.


Recommended for you:

Illustration of arrows pointing at circle

What Is HUMIRA?

Illustration of a video player

HUMIRA Patient Stories